Clinical Trials Browser

Phase 3 × OTHER × Loperamide × Clear all

NCT07016737 2025-06-12

ESO-Nanjing12

Phase 3 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02266849 2016-10-11

Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

Phase 3 Terminated

Gastrointestinal

Colitis, Ulcerative, Rectal Neoplasms, Short Bowel Syndrome